Raptim Research Ltd. is a quality-oriented, full-service contract (clinical) research organization providing end-to-end services to the global pharmaceutical (generic and research-based), biotechnology and cosmetic industries. Studies conducted at Raptim are submitted and approved globally by regulatory agencies including the US FDA, EMA, UK MHRA, Health Canada (TPD) and WHO; incorporated in 2005, Raptim has facilities in Navi Mumbai and business offices in Navi Mumbai and New Jersey, USA, leading in bioequivalence/bioavailability studies, PK and PD endpoint studies, Phase II-IV clinical trials, and studies in special populations, alongside pioneering expertise in testing dermal topical products, including cosmetics, and inhalation products.
No comments available.
Leave your rating & comment